Main Article Content

Biobele Jotham Brown
Hannah O Dada-Adegbola
Catherine Trippe
Olufunmilayo Olopade


Anemia, bacterial infection, sickle cell


Background & Objectives: As a result of immune defects in Sickle cell disease (SCD), affected individuals are prone to infection from encapsulated bacterial pathogens like Streptococcus Pneumoniae. Studies on the etiological agents of bacteremia in children with SCD in Nigeria are few and have revealed a spectrum of organisms that is different from those recorded in other parts of the world.  

Aim and Objectives: The objectives of this study were to determine the prevalence of bacteremia, etiological agents and antibiotic susceptibility pattern in febrile children with SCD attending the University College Hospital (UCH), Ibadan, Nigeria.

Methods: The study was cross-sectional and took place at the Department of Pediatrics of the UCH, Ibadan. Children with SCD, ages 0-17 years presenting with axillary temperature ? 380C were enrolled after obtaining informed consent.  History was obtained and complete physical examination performed after which blood was collected for culture and antibacterial susceptibility tests.

Results: A total of 116 children were studied of which 69 (59.5%) were males, 111 (95.7%) were of the Hemoglobin SS phenotype and 5 (4.3%) of the Hemoglobin SC phenotype. Bacteremia was present in 16 (13.8%) of the 116 children. Gram negative bacteria constituted 10 (62.5%) of all isolates, while the predominant isolates were Klebsiella pneumonia 4, (25%) and Staphylococcus aureus, 4 (25%). Over 80% of the isolates were susceptible to Ceftriaxone, Amikacin and Meropenem.

Conclusions Klebsiella pneumonia and Staphylococcus aureus are the predominant causes of bacteremia in children with SCD in Ibadan, contrary to findings in western countries.


Download data is not yet available.
Abstract 1960 | PDF Downloads 598 HTML Downloads 926


1. World Health Organization (2006). Sickle cell anaemia. WHO Fifty-Ninth World Assembly A59/9.

2. Obaro S. Pneumococcal infections and sickle cell disease in Africa: does absence of evidence imply evidence of absence? Arch Dis Child. 2009; 94:713–716.

3. Okuonghae HO, Nwankwo MU, Offor EC. Pattern of bacteraemia in febrile children with sickle cell anaemia. Ann Trop Paediatr. 1993; 13:55-64.

4. Brown BJ, Jacob NE, Lagunju I A, Jarrett OO. Morbidity and mortality pattern in hospitalized children with sickle cell disorders at the University College Hospital, Ibadan, Nigeria. Nig J Paediatr. 2013; 40: 34-39.

5. Leiken SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children and adolescents with sickle cell disease. Pediatrics 1989; 84:500-8.

6. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004; 103: 4023–4027.

7. Akinyanju O, Johnson AO. Acute illness in Nigerian children with sickle cell anaemia. Ann Trop Paediatr. 1987; 7: 181-6.

8. Akuse RM. Variation in the pattern of bacterial infection in patients with sickle cell disease requiring admission. J Trop Paediatr 1996; 42: 318-323.

9. Williams TN, Uyoga S, Macharia A, Ndila C, McAuley CF, Opi DH, Mwarumba S, Makani J, Komba A, Ndiritu MN, Sharif SK, Marsh K, Berkley JA, Scott JA. Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case–control study. Lancet 2009 ;374:1364–70.

10. Galadanci N, Wudil BJ, Balogun TM, Ogunrinde GO, Akinsulie A, Hasan-Hanga F, Mohammed AS, Kehinde MO, Olaniyi JA, Diaku-Akinwumi IN, Brown BJ, Adeleke S, Nnodu OE, Emodi I, Ahmed S, Osegbue AO, Akinola N, Opara HI, Adegoke SA, Aneke J, Adekile AD. Current sickle cell disease management practices in Nigeria. Int Health. 2014;6:23–8.

11. Cheesbrough, M. Biochemical tests to identify bacteria. In: District Laboratory Practice in Tropical Countries (Part 2). Low priced edn. Cambridge University Press. U.K: 2002. pp 62– 70.

12. Clinical and Laboratory Standard Institute (CLSI) for culture, identification and antibiotic susceptibility of bacterial

13. Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotics Susceptibility testing by a standardized single disc method. AMJ Clin Pathol 1966; 45: 493.

14. Bansil NH, Kim TY, Tieu L, Barcega B. Incidence of Serious Bacterial Infections in Febrile Children With Sickle Cell Disease. Clin Pediatr (Phila). 2013;52:661–6.

15. Morrissey BJ, Bycroft TP, Almossawi O, Wilkey OB, Daniels JG. Incidence and Predictors of Bacterial infection in Febrile Children with Sickle Cell Disease. Hemoglobin. 2015;39:316–9.

16. Aken’ova YA, Bakare RA, Okunade MA. Septicaemia in sickle cell anaemia patients: the Ibadan experience. Cent Afri J Med 1998; 44:102–4.

17. Akuse RM. Variation in the pattern of bacterial infection in patients with sickle cell disease requiring admission. J Trop Pediatr. 1996 ;42:318–23.

18. Kizito ME, Mworozi E, Ndugwa C, Serjeant GR. Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified? Arch Dis Child. 2007;92:21–3.

19. Makani J, Mgaya J, Balandya E, Msami K, Soka D, Cox SE, Komba AN, Rwezaula S, Meda E, Muturi D, Kitundu J, Fegan G, Kirkham FJ, Newton CR, Snow RW, Lowe B. Bacteraemia in sickle cell anaemia is associated with low haemoglobin: a report of 890 admissions to a tertiary hospital in Tanzania. Br J Haematol. 2015;171:273.

20. Kateete DP, Kajumbula H, Kaddu-Mulindwa DH, Ssevviri AK. Nasopharyngeal carriage rate of Streptococcus pneumoniae in Ugandan children with sickle cell disease. BMC Res Notes 2012;5:28.

21. Centers for Disease Control and Prevention. Progress in Introduction of Pneumococcal Conjugate Vaccine — Worldwide, 2000–2012. Morb Mortal Wkly Rep. 2013;62(16):306–11.

22. Sistanizad M, Kouchek M, Miri M, Goharani R, Solouki M, Ayazkhoo L, Foroumand M, Mokhtari M. Carbapenem Restriction and its Effect on Bacterial Resistance in an Intensive Care unit of a Teaching Hospital. Iran J Pharm Res IJPR. 2013;12:503–9.